Q3 FY2025 Earnings
Financial report interval: 2025.06.30 - 2025.09.30
Overview: Clearside Biomedical(CLSD) the Revenue is 201 K (-80.64%);the EBIT is -7.04 M (-18.64%);the EPS is -1.14 (+26.04%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B80.64%
----
----
EBIT
-0.01B18.64%
----
----
EPS
-1.14126.04%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf